Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 8 |
GO:0043226 | organelle | 2 | 8 |
GO:0043227 | membrane-bounded organelle | 3 | 8 |
GO:0043229 | intracellular organelle | 3 | 8 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 4 | 1 |
GO:0005849 | mRNA cleavage factor complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: A0A3S5H5G4
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006378 | mRNA polyadenylation | 7 | 1 |
GO:0006379 | mRNA cleavage | 7 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006397 | mRNA processing | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0031123 | RNA 3'-end processing | 7 | 1 |
GO:0031124 | mRNA 3'-end processing | 8 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043631 | RNA polyadenylation | 6 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 1 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 1 |
GO:0098787 | mRNA cleavage involved in mRNA processing | 8 | 1 |
GO:0098789 | pre-mRNA cleavage required for polyadenylation | 9 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 9 |
GO:0043167 | ion binding | 2 | 9 |
GO:0043169 | cation binding | 3 | 9 |
GO:0046872 | metal ion binding | 4 | 9 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 21 | 25 | PF00656 | 0.737 |
CLV_C14_Caspase3-7 | 333 | 337 | PF00656 | 0.800 |
CLV_PCSK_KEX2_1 | 347 | 349 | PF00082 | 0.679 |
CLV_PCSK_KEX2_1 | 72 | 74 | PF00082 | 0.357 |
CLV_PCSK_PC1ET2_1 | 347 | 349 | PF00082 | 0.706 |
CLV_PCSK_PC1ET2_1 | 72 | 74 | PF00082 | 0.376 |
CLV_PCSK_PC7_1 | 343 | 349 | PF00082 | 0.702 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.618 |
DOC_ANK_TNKS_1 | 349 | 356 | PF00023 | 0.595 |
DOC_CKS1_1 | 286 | 291 | PF01111 | 0.801 |
DOC_CYCLIN_yCln2_LP_2 | 310 | 313 | PF00134 | 0.710 |
DOC_PP2B_LxvP_1 | 310 | 313 | PF13499 | 0.710 |
DOC_PP4_FxxP_1 | 342 | 345 | PF00568 | 0.706 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.521 |
DOC_WW_Pin1_4 | 285 | 290 | PF00397 | 0.793 |
LIG_14-3-3_CanoR_1 | 210 | 216 | PF00244 | 0.386 |
LIG_BIR_III_2 | 24 | 28 | PF00653 | 0.758 |
LIG_BRCT_BRCA1_1 | 59 | 63 | PF00533 | 0.668 |
LIG_BRCT_BRCA1_1 | 82 | 86 | PF00533 | 0.369 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.588 |
LIG_FHA_2 | 32 | 38 | PF00498 | 0.701 |
LIG_Integrin_RGD_1 | 222 | 224 | PF01839 | 0.416 |
LIG_LIR_Apic_2 | 285 | 290 | PF02991 | 0.577 |
LIG_LIR_Apic_2 | 340 | 345 | PF02991 | 0.755 |
LIG_LIR_Nem_3 | 83 | 88 | PF02991 | 0.357 |
LIG_LIR_Nem_3 | 92 | 98 | PF02991 | 0.333 |
LIG_MLH1_MIPbox_1 | 82 | 86 | PF16413 | 0.369 |
LIG_Pex14_2 | 86 | 90 | PF04695 | 0.357 |
LIG_PTB_Apo_2 | 201 | 208 | PF02174 | 0.595 |
LIG_PTB_Apo_2 | 84 | 91 | PF02174 | 0.357 |
LIG_PTB_Phospho_1 | 201 | 207 | PF10480 | 0.610 |
LIG_SH2_CRK | 182 | 186 | PF00017 | 0.795 |
LIG_SH2_CRK | 287 | 291 | PF00017 | 0.767 |
LIG_SH2_GRB2like | 85 | 88 | PF00017 | 0.357 |
LIG_SH2_NCK_1 | 287 | 291 | PF00017 | 0.785 |
LIG_SH2_SRC | 65 | 68 | PF00017 | 0.391 |
LIG_SH2_STAP1 | 65 | 69 | PF00017 | 0.492 |
LIG_SH2_STAT3 | 170 | 173 | PF00017 | 0.724 |
LIG_SH2_STAT3 | 357 | 360 | PF00017 | 0.738 |
LIG_SH2_STAT5 | 163 | 166 | PF00017 | 0.553 |
LIG_SH2_STAT5 | 287 | 290 | PF00017 | 0.758 |
LIG_SH2_STAT5 | 309 | 312 | PF00017 | 0.730 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.357 |
LIG_SH3_1 | 182 | 188 | PF00018 | 0.790 |
LIG_SH3_1 | 286 | 292 | PF00018 | 0.788 |
LIG_SH3_1 | 343 | 349 | PF00018 | 0.804 |
LIG_SH3_2 | 301 | 306 | PF14604 | 0.738 |
LIG_SH3_3 | 139 | 145 | PF00018 | 0.635 |
LIG_SH3_3 | 182 | 188 | PF00018 | 0.790 |
LIG_SH3_3 | 240 | 246 | PF00018 | 0.739 |
LIG_SH3_3 | 286 | 292 | PF00018 | 0.734 |
LIG_SH3_3 | 298 | 304 | PF00018 | 0.657 |
LIG_SH3_3 | 324 | 330 | PF00018 | 0.749 |
LIG_SH3_3 | 343 | 349 | PF00018 | 0.740 |
LIG_SH3_3 | 353 | 359 | PF00018 | 0.658 |
LIG_SUMO_SIM_anti_2 | 66 | 71 | PF11976 | 0.492 |
LIG_TRAF2_1 | 100 | 103 | PF00917 | 0.492 |
LIG_TRAF2_2 | 349 | 354 | PF00917 | 0.593 |
MOD_CK1_1 | 285 | 291 | PF00069 | 0.646 |
MOD_CK1_1 | 59 | 65 | PF00069 | 0.672 |
MOD_CK2_1 | 211 | 217 | PF00069 | 0.386 |
MOD_CK2_1 | 31 | 37 | PF00069 | 0.666 |
MOD_GlcNHglycan | 266 | 269 | PF01048 | 0.785 |
MOD_GlcNHglycan | 295 | 298 | PF01048 | 0.633 |
MOD_GlcNHglycan | 333 | 336 | PF01048 | 0.792 |
MOD_GlcNHglycan | 339 | 342 | PF01048 | 0.822 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.632 |
MOD_N-GLC_1 | 111 | 116 | PF02516 | 0.647 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.309 |
MOD_NEK2_2 | 38 | 43 | PF00069 | 0.525 |
MOD_Plk_1 | 105 | 111 | PF00069 | 0.570 |
MOD_Plk_1 | 91 | 97 | PF00069 | 0.358 |
MOD_Plk_4 | 105 | 111 | PF00069 | 0.575 |
MOD_Plk_4 | 282 | 288 | PF00069 | 0.712 |
MOD_ProDKin_1 | 285 | 291 | PF00069 | 0.791 |
TRG_DiLeu_BaEn_1 | 144 | 149 | PF01217 | 0.543 |
TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.351 |
TRG_NES_CRM1_1 | 37 | 51 | PF08389 | 0.669 |
TRG_NLS_MonoCore_2 | 346 | 351 | PF00514 | 0.807 |
TRG_NLS_MonoExtC_3 | 346 | 352 | PF00514 | 0.751 |
TRG_NLS_MonoExtN_4 | 345 | 351 | PF00514 | 0.750 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5N7 | Leptomonas seymouri | 53% | 100% |
A0A0S4JNN9 | Bodo saltans | 33% | 100% |
A4H465 | Leishmania braziliensis | 79% | 97% |
A4HSD3 | Leishmania infantum | 99% | 100% |
C9ZPW6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
E9AKC3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
Q4QJI4 | Leishmania major | 89% | 100% |